Tainted drug death toll rises to 14 in US

The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

That's up from 12 deaths and 137 cases on Wednesday.

Investigators say as many as 13,000 people in 23 states may have received contaminated doses of the steroid, which is typically injected into the spine to treat back pain.

The outbreak has led to calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.

Critics said have found a way to sidestep costly and strict oversight by classifying themselves as pharmacies, which are given freer rein to mix for patients.

Among the hardest hit states were Tennessee, with 49 cases and six deaths, Michigan, with 39 cases and three deaths, and Virginia, with 30 cases and one death.

Idaho reported its first case on Wednesday and Thursday Ohio reported two new cases after the posted the national tally.

Ohio said it has been able to contact 419 of the state's 422 patients who received received the possibly tainted injections.

"This outreach and contact with needs to continue even if the patient is feeling well during the initial conversation," said Dr. Ted Wymyslo, director of the Ohio Department of Health.

"Because of the rare nature of this infection, no one is sure of the ; we don't know how long after an injection it is safe to say you won't get sick."

The rare —which inflames the protective membranes covering the brain and spinal cord—often goes undetected until it is too late because its flu-like symptoms can be mild at first.

Treatment requires a hospital stay and intravenous anti-fungal medications. But meningitis is not contagious in this form.

US health officials launched an investigation after the first case was discovered in September and discovered fungal contaminants in steroids produced by the New England Compounding Center.

The Massachusetts-based company subsequently issued a voluntary recall of all of its products and shut down all operations.

A second manufacturing pharmacy owned by the same people, Ameridose and its distributor Alanaus, temporarily suspended operations on Wednesday but did not recall any products.

Massachusetts said there is "no evidence to suggest that there is direct concern for compromised product manufactured or compounded by Ameridose" but that the suspension will allow for a thorough investigation.

add to favorites email to friend print save as pdf

Related Stories

7 dead in spreading US meningitis outbreak

Oct 08, 2012

At least seven people have died and 91 have fallen ill in the United States in a worsening meningitis outbreak tied to a contaminated drug, updated figures showed Sunday.

US pharmacy linked to outbreak issues wide recall

Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

US clinics rush to warn of tainted steroid; 5 dead

Oct 05, 2012

(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five ...

Recommended for you

Hong Kong makes Ebola 'contingency' measures

1 hour ago

Hong Kong said Wednesday it was quarantining all people from Guinea, Sierra Leone and Liberia who were showing Ebola-like symptoms on arrival in the city, as fears grow worldwide about the spread of the deadly virus.

EU ready for Ebola threat: sources

4 hours ago

The European Union is equipped and ready to treat victims should the deadly Ebola virus, which has killed hundreds in West Africa, be found in member states, EU sources said Wednesday.

Reducing kidney injury using a quality improvement method

8 hours ago

Using quality improvement measures in eight of the 10 hospitals in the Northern New England Cardiovascular Disease Study Group, researchers have found a way to reduce kidney injury in patients undergoing a procedure with ...

App for headache sufferers shows success

20 hours ago

A unique app that helps headache sufferers to record the severity and regularity of their pain is being used as part of a Griffith research study.

User comments